HRS: Bariatric surgery may prevent A-fib onset in obese

HRS: bariatric surgery may prevent A-fib onset in obese

(HealthDay)—Bariatric surgery may prevent the development of atrial fibrillation in morbidly obese patients, according to research presented at the annual meeting of the Heart Rhythm Society, held from May 7 to 10 in San Francisco.

Hongtao Yuan, M.D., and colleagues analyzed data for 438 patients (mean age, 59 ± 11 years; 81.1 percent female) with (BMI) greater than 40 kg/m² who received (326 patients) or served as controls (112 patients). The authors sought to assess the effect of bariatric surgery on incidence of atrial fibrillation.

The researchers found that the group receiving bariatric surgery had a significant reduction in BMI compared with the control group (−12.1 ± 0.4 kg/m² versus 0.2 ± 0.7 kg/m²; P < 0.001) and some improvements in metabolic profile. The incidence of atrial fibrillation was comparable in the groups at baseline. At a median of 7.2 ± 3.5 years, the incidence of atrial fibrillation was significantly lower in patients who received bariatric surgery than in those who did not receive surgery (6.4 versus 16.1 percent; P < 0.01).

"Bariatric surgery has a preventive effect on the incidence of in patients with morbid obesity," the authors write.

More information: Abstract
More Information

add to favorites email to friend print save as pdf

Related Stories

Weight-loss surgery can reduce liver damage

May 04, 2014

Bariatric surgery, which is best known for its ability to help patients lose substantial weight, can also result in significant improvement in nonalcoholic fatty liver disease (NAFLD), according to new research presented ...

Recommended for you

An autoimmune response may contribute to hypertension

18 hours ago

High blood pressure is a major risk factor for heart attack, stroke, chronic heart failure, and kidney disease. Inflammation is thought to promote the development of high blood pressure, though it is not clear what triggers ...

Results of RIBS IV trial reported

Sep 16, 2014

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

Results of DKCRUSH-VI trial reported

Sep 16, 2014

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The DKCRUSH-VI clinical trial ...

User comments